MIRA
INFORM REPORT
|
Report Date : |
18.12.2012 |
IDENTIFICATION DETAILS
|
Name : |
CRYSTAL PHARMA SA |
|
|
|
|
Registered Office : |
Lugar Parque Tecnologico De
Boecillo, 105, 47151 Boecillo Valladolid |
|
|
|
|
Country : |
Spain |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
01.02.1996 |
|
|
|
|
Legal Form : |
Sole Corporation |
|
|
|
|
Line of Business : |
Manufacturer of basic pharmaceutical products |
|
|
|
|
No. of Employees : |
200 employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
|
With financials |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
Spain |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
spain - ECONOMIC OVERVIEW
spain's mixed capitalist economy is the 13th largest
in the world, and its per capita income roughly matches that of Germany and
France. However, after almost 15 years of above average GDP growth, the Spanish
economy began to slow in late 2007 and entered into a recession in the second
quarter of 2008. GDP contracted by 3.7% in 2009, ending a 16-year growth trend,
and by another 0.1% in 2010, before turning positive in 2011, making Spain the
last major economy to emerge from the global recession. The reversal in
Spain''s economic growth reflected a significant decline in construction amid
an oversupply of housing and falling consumer spending, while exports actually
have begun to grow. Government efforts to boost the economy through stimulus spending,
extended unemployment benefits, and loan guarantees did not prevent a sharp
rise in the unemployment rate, which rose from a low of about 8% in 2007 to
over 20% in 2011. The government budget deficit worsened from 3.8% of GDP in
2008 to 9.2% of GDP in 2010, more than three times the euro-zone limit. Madrid
cut the deficit to 8.5% of GDP in 2011, a larger deficit than the 6% target
negotiated between Spain and the EU. Spain''s large budget deficit and poor
economic growth prospects have made it vulnerable to financial contagion from
other highly-indebted euro zone members despite the government''s efforts to
cut spending, privatize industries, and boost competitiveness through labor
market reforms. Spanish banks'' high exposure to the collapsed domestic
construction and real estate market also poses a continued risk for the sector.
The government oversaw a restructuring of the savings bank sector in 2010, and
provided some $15 billion in capital to various institutions. Investors remain
concerned that Madrid may need to bail out more troubled banks. The Bank of
Spain, however, is seeking to boost confidence in the financial sector by
pressuring banks to come clean about their losses and consolidate into stronger
groups.
|
Source : CIA |
Company name
CRYSTAL PHARMA SA
CIF/NIF: A40147753
Company situation: Active
Data of your
request
|
|
|
|
Registered Name CRYSTAL PHARMA Complete Address PARQUE
TECNOLOGICO DE BOECILLO, 105 47 47151 |
Year of the accounts to be delivered 2011 Language Inglés Delivery Method E-mail Delivery Format RTF Delivery time 4 days Report Reference
Number 203281 |
Answer to the data
in your request
The data of your request have been confirmed and are correct.
EXECUTIVE SUMMARY
Identification
Current Business Name: CRYSTAL PHARMA SA
Other names: YES
Current Address: LUGAR PARQUE TECNOLOGICO DE
BOECILLO, 105
Telephone number: 983548072 Fax: 983548113
URL: www.crystalpharma.com
Corporate e-mail: crystalpharma@crystalpharma.com
Trade Risk
Incidents: NO
R.A.I.: NO
Financial Information
Balance sheet latest sales (2011): 49.097.000,00 € (Mercantile Register)
Result: 7.128.000 €
Total Assets: 44.728.000 €
Share capital: 2.000.000,00 €
Employees: 200
Listed on a Stock Exchange: NO
Commercial
Information
Incorporation date: 01/02/1996
Activity: Mfg. of basic pharmaceutical products
NACE 2009 CODE: 2110
International Operations: Imports and
Exports
Corporate
Structure
Sole Administrator:
GADEA
PHARMACEUTICAL GROUP S L
Parent Company:
Other
Complementary Information
Latest filed accounts in the Mercantile Register: 2011
Latest act published in BORME: 27/01/2012 Takeover merger
Latest press article: 10/09/2012 EL
ECONOMISTA (GENERAL INFORMATION)
Bank Entities: There are
The date when this report was last updated is 14/12/2012.
The information contained in this report has been investigated and
contrasted on 23/05/2012
Financial
situation
|
Exercise:2011 |
Evolution |
|||
|
Immediate
liquidity |
|
Acceptable |
|
|
|
Indebtedness |
|
Slight |
|
|
|
Profitability |
|
Good |
|
|
|
Soundness |
|
Very good |
|
|
Performance
|
Incidents |
None or Negligible |
|
Business
Trajectory |
Excellent |
Rating
Explanation
Financial situation
•
The company’s financial situation is good.
•
The company’s financial situation evolution has
been stable.
•
The sales evolution and results has
been positive.
•
The auditor’s opinion about the latest accounts has
been favourable.
Company Structure
•
The company’s capitalization degree determines that
its structure is sound.
•
The company’s size is big depending on
its sales volume.
•
The employees evolution has been positive.
Performance and Incidences
•
The available information indicates that the
company does not have payment incidences.
•
He have detected no recent legal actions or claims
from the Administration against this company.
Accounts Filing
•
The company files regularly its accounts.
Reasons of the
last outstanding calculation in the note
|
DATE |
CHANGE |
RESULTING NOTE |
EVENT |
|
30/11/2012 |
Reduction |
16 |
•
There has been a change in the formula version. |
|
06/09/2012 |
Increase |
18 |
•
New financial statements have been uploaded. |
|
01/10/2011 |
Equal |
17 |
•
New financial statements have been uploaded. |
Summary
LEGAL ACTIONS: No legal actions registered
ADMINISTRATIVE CLAIMS: No administrative claims registered
AFFECTED BY: No significant element.
R.A.I.
COMPANY NOT REGISTERED IN THE R.A.I.
This company is not registered in the Disputed Bills register (R.A.I.)
DATE AND TIME OF THE CONSULTATION
10/12/2012 09:12:33
Information from the Registro de Aceptaciones Impagados (RAI)- Disputed
Bills register.
It can only be used for information legitimate needs of the consulting
party, in accordance with its social or business activity, in order to grant a
credit or the monitoring or control of the already granted credits and can not
be transmitted or communicated to thirds, nor copied, duplicated, reproduced
nor implemented to any database , owned or external, or reused it in anyway, direct
or indirectly.
FINANCIAL ELEMENTS AND SECTORIAL COMPARATIVE
FINANCIAL ELEMENTS
Figures given in thousands €
|
|
31/12/2011 (12) BALANCE SHEET |
% ASSETS |
31/12/2010 (12) BALANCE SHEET |
% ASSETS |
31/12/2009 (12) BALANCE SHEET |
% ASSETS |
|
ASSETS |
|
|
|
|
|
|
|
A) NON CURRENT ASSETS |
13.323,00 |
29,79 |
9.265,48 |
28,72 |
11.008,84 |
40,44 |
|
B) CURRENT ASSETS |
31.405,00 |
70,21 |
22.997,08 |
71,28 |
16.215,07 |
59,56 |
|
LIABILITIES |
|
|
|
|
|
|
|
A) NET WORTH |
26.180,00 |
58,53 |
13.160,44 |
40,79 |
13.195,16 |
48,47 |
|
B) NON CURRENT LIABILITIES |
3.331,00 |
7,45 |
9.105,59 |
28,22 |
1.455,95 |
5,35 |
|
C) CURRENT LIABILITIES |
15.217,00 |
34,02 |
9.996,52 |
30,98 |
12.572,79 |
46,18 |
Profit and loss
account analysis 
Figures given in thousands €
|
|
31/12/2011 (12) BALANCE SHEET |
% NET TURNOVER |
31/12/2010 (12) BALANCE SHEET |
% NET TURNOVER |
31/12/2009 (12) BALANCE SHEET |
% NET TURNOVER |
|
SALES |
49.097,00 |
|
33.367,84 |
|
22.716,87 |
|
|
GROSS MARGIN |
25.876,00 |
52,70 |
13.964,93 |
41,85 |
11.219,12 |
49,39 |
|
EBITDA |
14.247,00 |
29,02 |
6.408,48 |
19,21 |
5.064,27 |
22,29 |
|
EBIT |
9.772,00 |
19,90 |
4.292,62 |
12,86 |
3.133,94 |
13,80 |
|
NET RESULT |
7.128,00 |
14,52 |
2.897,93 |
8,68 |
2.164,55 |
9,53 |
|
EFFECTIVE TAX RATE (%) |
24,72 |
0,05 |
28,93 |
0,09 |
23,80 |
0,10 |
COMPARATIVE SECTOR
ANALYSIS
Values table
Figures expressed in %
|
|
COMPANY (2011) |
SECTOR |
DIFFERENCE |
|
BALANCE SHEET ANALYSIS: % on the total
assets |
|
|
|
|
ASSETS |
|||
|
A) NON CURRENT ASSETS |
29,79 |
29,69 |
0,09 |
|
A) CURRENT ASSETS |
70,21 |
70,31 |
-0,09 |
|
LIABILITIES |
|||
|
A) NET WORTH |
58,53 |
49,70 |
8,83 |
|
B) NON CURRENT LIABILITIES |
7,45 |
6,41 |
1,03 |
|
C) CURRENT LIABILITIES |
34,02 |
43,88 |
-9,86 |
|
|
|
|
|
|
|
COMPANY (2011) |
SECTOR |
DIFFERENCE |
|
PROFIT AND LOSS ACCOUNT ANALYSIS: % on the total
operating income |
|
|
|
|
SALES |
98,49 |
95,69 |
2,80 |
|
GROSS MARGIN |
51,91 |
42,34 |
9,56 |
|
EBITDA |
28,58 |
8,74 |
19,84 |
|
EBIT |
19,60 |
6,37 |
13,23 |
|
NET RESULT |
14,30 |
4,89 |
9,41 |
Sector
Composition
Compared sector (NACE 2009): 211
Number of companies: 12
Size (sales figure): > 40,000,000.00 Euros
OTHER DATA FROM
THE ANNUAL FINANCIAL REPORT
Results Distribution
Source: annual financial report 2011
Figures given in €
|
DISTRIBUTION BASE |
APPLICATION A |
||
|
Profit and Loss Account Balance |
7.128.000,00 |
Legal Reserve |
0,00 |
|
Carry over |
0,00 |
Goodwill reserve |
35.000,00 |
|
Voluntary reserves |
0,00 |
Special reserves |
0,00 |
|
Other reserves disposable at will |
0,00 |
Voluntary reserves |
4.693.000,00 |
|
Total of Amounts to be distributed |
7.128.000,00 |
Dividends |
2.400.000,00 |
|
|
|
Carry over and others |
0,00 |
|
|
|
Compensation of previous exercises losses |
0,00 |
|
|
|
Application total |
7.128.000,00 |
Auditing
Source: filing of annual financial statement 2011
Auditors’ opinion: FAVOURABLE
Auditor: ERNST & YOUNG S.L.
Auditing fees: 34.000,00 €
Facts subsequent
to the closing
Source: Annual financial report 2011
En los primeros días de Febrero de 2012, la Sociedad se ha personado en
el proceso de arbitraje instado ante la Corte Internacional de Arbitraje de la
Cámara Internacional de Comercio por uno de sus clientes (agente comercial en
el mercado norteamericano) contra un cliente final (fabricante de fármacos
genéricos) en reclamación del pago de unas ventas efectuadas en julio de 2011 y
no pagadas en su totalidad a la fecha actual. Como consecuencia de las ventas
seńaladas, la Sociedad tenía una cuenta a cobrar a su agente comercial por
importe de 2.257 miles de euros, de los que se ha recibido un pago inicial del
cliente final por el 25% del importe total. Los administradores de la Sociedad
consideran que en fechas próximas se producirá una resolución del asunto en
cuestión, favorable para sus intereses, ya sea mediante el alcance de un
acuerdo amistoso o mediante la resolución arbitral favorable, por lo que el
mencionado importe no ha sido considerado susceptible de deterioro al cierre
del ejercicio 2011.
company ADDRESSES
Current Legal Seat Address:
LUGAR PARQUE TECNOLOGICO DE BOECILLO, 105
47151 BOECILLO VALLADOLID
Previous Seat Address:
CALLE SAN GEROTEO 11
40003 SEGOVIA
CORPORATE STRUCTURE
ADMINISTRATIVE
LINKS
Governing body : 1 member (latest change:
07/06/2007)
Other Positions : 1 (latest change: 17/07/2008)
Auditor : 1 (latest change: 08/04/2011)
Operative Board Members : 6 (latest change: 23/05/2012)
Non-current positions : 13 (latest change: 14/06/2010)
Main Board
members, Directors and Auditor
Governing body
|
POSITION |
NAME AND SURNAME |
DATE APPOINTMENT |
|
SOLE ADMINISTRATOR |
GADEA PHARMACEUTICAL GROUP S L |
07/06/2007 |
|
|
|
|
Auditor
|
POSITION |
NAME AND SURNAME |
DATE APPOINTMENT |
|
AUDITOR |
ERNST & YOUNG SL |
08/04/2011 |
There are 3 board members, directors and auditors registered
Board members remuneration
Source: Annual
financial report 2011
Board
members remuneration: 0,00 €
|
POSITION |
NAME AND SURNAME |
|
General Manager |
GALLO NIETO, FRANCISCO JAVIER |
|
Financial Manager |
ALONSO MARTÍNEZ, SAMUEL |
|
Commercial Director |
ALONSO SANTOS, SARA |
|
Exports Director |
ALONSO SANTOS, SARA |
|
Imports Director |
MARTÍNEZ PÉREZ, JOSÉ MARÍA |
|
Operations Director |
MARTÍNEZ PÉREZ, JOSÉ MARÍA |
FINANCIAL LINKS
|
|
BUSINESS NAME |
TAX NUMBER/COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
GADEA GRUPO FARMACEUTICO SL. |
B47596390 |
100,00 |
OWN SOURCES |
23/05/2012 |
There are 1 direct financial links through shareholders
registered
Majority shareholder of GADEA GRUPO FARMACEUTICO SL.
|
|
BUSINESS NAME |
TAX NUMBER/COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
TENDEŃA XXI SL |
B47592498 |
35,81 |
MERCANTILE REGISTER |
31/12/2011 |
|
|
BUSINESS NAME |
TAX NUMBER/COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
TENDEŃA XXI SL |
B47592498 |
51,29 |
MERCANTILE REGISTER |
31/12/2006 |
|
|
RAGACTIVES S.L. (EXTINGUIDA) |
B80096357 |
51,00 |
B.O.R.M.E. |
28/12/2006 |
|
|
GENTEC SA |
A58013293 |
35,26 |
B.O.R.M.E. |
07/06/2007 |
Company with rating inferior to 7
|
|
BUSINESS NAME |
TAX NUMBER/COUNTRY |
% |
SOURCE |
DATE REP. |
|
|
BLASCHEM LTD |
MALTA |
100,00 |
MERCANTILE REGISTER |
31/12/2010 |
|
|
SOCIEDAD TECNICA DE AVALES SOCIEDAD DE GARANTIA RECIPROCA (EXTINGUIDA) |
G47025143 |
Indef. |
MERCANTILE REGISTER |
30/06/1997 |
Company with rating inferior to 7
POTENTIAL LINKS
Search for Link by
Administrator
Search
Criterion: ”GADEA PHARMACEUTICAL
GROUP S L”
|
COMPANY |
POSITION |
PROVINCE |
|
CYNDEA PHARMA SL |
Presidente |
SORIA |
In case you need more information you can request:Board Members
Monitoring
Search Criterion: ”CRYSTAL PHARMA”
URL: www.gadea.com
Crystal Pharma. Gadea Grupo Farmacéutico. Crystal
Pharma. Gadea Grupo Farmacéutico is an independent Spanish group of affiliated
companies dedicated to the technical development services, ...
BUSINESS INFORMATION
Incorporation date: 01/02/1996
Activity: Mfg. of basic pharmaceutical products
NACE 2009 CODE: 2110
NACE 2009 Activity: Manufacture of basic pharmaceutical products
Business: FABRICACION, COMERCIALIZACION, PLANIFICACION,
ESTUDIO, PROGRAMACION, ADQUISICION, MANIPULACION Y TRAFICO. INTERIOR Y EXTERIOR
DE MATERIAS PRIMAS, DE PRODUCTOS INTERMEDIOS, SEMIELABORADOS Y ELABORADOS,
DESTINADOS A LA IND
(Enlargement)1. Fabricación, comercialización, planificación, estudio,
programación, adquisición, manipulación y tráfico interior y exterior de
materias primas, de productos intermedios, semielaborados y elaborados,
destinados a la industria química, farmacéutica, cosmética, veterinaria y
agroalimentaria, excep.
Activity description: FABRICACION DE PRODUCTOS FARMACEUTICOS
Latest employees figure: 200 (2012)
% of fixed employees: 89,21%
% of temporary employees: 10,79%
% of men: 69,39%
% of women: 30,61%
Employees
evolution
|
|
|
|
Source: Annual financial report 2011
|
CATEGORY |
AVERAGE NUMBER OF EMPLOYEES |
MEN |
WOMEN |
|
Distribution by sexes |
|
102 |
45 |
COMMERCIAL OPERATIONS
PURCHASES
Import Percentage: 88%
Imports from: UE Y OTROS PAÍSES
National Distribution: 12%
SALES
Export Percentage: 89%
Exports to: UE Y OTROS PAÍSES
National Distribution: 11%
SUPPLIERS
|
BUSINESS NAME |
INTERNATIONAL |
|
CRYSTAL PHARMA,
LTD |
YES |
|
CYNDEA PHARMA,
S.L. |
NO |
|
GENTEC, S.A. |
NO |
|
SOLEA PHARMA LTD |
YES |
There are 4 Suppliers
CLIENTS
|
BUSINESS NAME |
INTERNATIONAL |
|
GENTEC, S.A. |
NO |
|
CYNDEA PHARMA,
S.L. |
NO |
|
RAGACTIVES SL |
NO |
There are 3 Clients
•
El 99,86% de su cifra de negocio corresponde a
ventas.
•
El 0,14% de su cifra de negocio corresponde a
prestación de servicios.
Professional and
advertising services
Source: Annual financial report 2011
Professional services
expenses: 1.771.000,00 €
|
ENTITY |
BRANCH |
ADDRESS |
TOWN OR CITY |
PROVINCE |
|
BANCO BILBAO VIZCAYA ARGENTARIA, S.A. |
|
|
VALLADOLID |
|
|
BANCO SANTANDER, S.A. |
|
|
VALLADOLID |
|
There are 2 bank entities registered
Discount facilities: 1
Credit policy: 1
Mortgage loan: 1
Loans with no real security: 1
|
|
|
|
Debt type: Credit policy |
Granted limit:991.000,00 € Used limit:0,00 € Available limit:991.000,00
€ Source: Filed
Accounts (2011) |
|
|
|
|
Debt type: Discount
facilities |
Granted limit:4.732.000,00 € Used limit:1.718.000,00
€ Available limit:3.014.000,00
€ Source: Filed
Accounts (2011) |
|
|
|
|
Debt type:Loans with no
real security Expiry date:18/11/2014 Date of the granting: 18/11/2010 |
Granted amount:2.500.000,00 € Total outstanding amount:1.863.000,00
€ Source: Filed
Accounts (2011) |
|
|
|
|
Entity:CAJA ESPAŃA DE INVERSIONES, SALAMANCA Y SORIA,CAMP Debt type:Mortgage loan Guarantee in a mortgage: Construcción
de la planta de cristalización estéril y micronizado de esteriodes ubicada en
el Parque Tecnológico de Boecillo (Valladolid). |
Granted amount:671.369,00 € Long term outstanding
amount:75.000,00 € Short term outstanding
amount:174.000,00 € Total outstanding amount:249.000,00
€ Source: Filed
Accounts (2011) |
|
|
|
There are 4 bank operations registered
Grants
|
|
|
|
Grant type: Other grants (grouped amounts or not
classified) Granting year: 2010 |
Nominal amount: 404.000,00 € Source: Filed
Accounts (2011) |
|
Operation description: Varias subvenciones de explotación, siendo
la más importante una recibida de la ADE, por un total de 393.000 euros, para
financiar los gastos de personal y de materiales del ejercicio
correspondiente incurridos en la realización de determinados proyectos de
innovación. |
|
|
|
|
|
Body-entity: JUNTA DE CASTILLA Y LEON Grant type: Financial
(capital, interests, etc) Granting year: 1997 |
Nominal amount: 503.000,00 € Amount received in the
exercise: 3.000,00 € Amount pending collection:
41.000,00 € Source: Filed
Accounts (2011) |
|
|
|
|
Body-entity: ADE Grant type: Financial
(capital, interests, etc) Granting year: 2001 |
Nominal amount: 123.000,00 € Amount pending collection:
16.000,00 € Source: Filed
Accounts (2011) |
|
Operation description: ampliación empresa |
|
|
|
|
There are 13 grants registered
Brand name: CRYSTAL PHARMA (Valid)
Type: GRAPHICAL Scope: COMMUNITARY
Date: 26/08/2009
There are 2 brands, signs and commercial names
LEGAL STRUCTURE
Constitution Data
Register Date: 01/02/1996
Register town: Segovia
Announcement number: 145729
Legal form: Sole Corporation
Share capital: 2.000.000,00 €
Paid-up capital: 2.000.000,00 €
Obligation to fill in Financial Statements: YES
Chamber census: YES (2009)
B.O.R.M.E.
(OFFICIAL GAZETTE
OF THE MERCANTILE REGISTER)
Acts on activity: 1 (Last: 27/01/2012)
Acts on administrators: 11 (Last: 08/04/2011, first:
07/05/1996)
Acts on capital: 6 (Last: 23/02/2004, first:
27/12/1996)
Acts on creation: 1 (Last: 07/05/1996)
Acts on filed accounts: 15 (Last: 27/09/2011, first:
22/10/1997)
Acts on identification: 1 (Last: 27/12/1996)
Acts on Information: 4 (Last: 27/01/2012, first:
27/12/1996)
Acts on proceedings: 3 (Last: 27/01/2012, first:
23/08/2011)
Latest acts in
B.O.R.M.E.
Most relevant acts of the last twelve months
|
|
ACT |
DATE |
NOTICE NUM. |
MERCANTILE REGISTER |
|
Takeover merger |
27/01/2012 |
43638 |
Valladolid |
|
|
|
Absorbed companies: RAGACTIVES SL Register Data:
Volume 937, Folio 42, Section 8, Sheet 7941, Inscription I/A
18 (18/01/2012) Publication Data:
Register Valladolid, Gazette 19, Page
4830, Announcement 43638 (27/01/2012) |
|||
|
Registered activity change |
27/01/2012 |
43638 |
Valladolid |
|
|
|
1. Fabricación, comercialización, planificación, estudio,
programación, adquisición, manipulación y tráfico interior y exterior de
materias primas, de productos intermedios, semielaborados y elaborados,
destinados a la industria química, farmacéutica, cosmética, veterinaria y
agroalimentaria, excep. Register Data:
Volume 937, Folio 42, Section 8, Sheet 7941, Inscription I/A
18 (18/01/2012) Publication Data:
Register Valladolid, Gazette 19, Page
4830, Announcement 43638 (27/01/2012) |
|||
Other acts
|
ACT |
DATE |
NOTICE NUM. |
MERCANTILE REGISTER |
|
Modification of the Articles of Association |
27/01/2012 |
43638 |
Valladolid |
|
Company’s mergers and takeovers |
14/10/2011 |
32294 |
|
|
Annual Filed Accounts (2010) |
27/09/2011 |
636695 |
Valladolid |
|
Takeover merger project filing |
23/08/2011 |
342212 |
Valladolid |
|
Re-elections |
08/04/2011 |
159072 |
Valladolid |
|
Annual Filed Accounts (2009) |
05/10/2010 |
755664 |
Valladolid |
|
Resignations |
14/06/2010 |
236834 |
Valladolid |
|
Annual Filed Accounts (2008) |
16/10/2009 |
674831 |
Valladolid |
There are 42 acts registered
PRESS ARTICLES
Press summary by
type of information (last five years)
Legal notices: 1 (Last: 14/10/2011)
Structural Data: 0
Informative data: 2 (Last: 10/09/2012, first: 15/04/2008)
Financial Information: 0
Negative information: 0
Business lines: 0
Historical press releases: 14 (Last: 18/11/2006, first:
16/12/1997)
Latest press
article published
10/09/2012 EL ECONOMISTA - GENERAL INFORMATION
El holding GADEA, que volverá a crecer este ańo por encima de los 2
dígitos, se encuentra ahora replanteando su plan de expansión, y busca en
Europa del Este alternativas a su planta de China, donde ha tropezado con su
socio local, y no detener así su plan de expansión. GADEA desecha la continuidad
de la cía. NORCHEM que creó en el país asiático, aunque baraja la posibilidad
de mantenerse en el país. GADEA, con su buque insignia CRYSTAL PHARMA al
frente, prevé alcanzar en 2016 una facturación de 131 millones. Por el momento,
a 31/08/12, la facturación ha crecido un 12%, y la previsión es cerrar el ańo
con ventas consolidadas de 56-57 millones (en 2011 fueron de 50,6
millones).
14/10/2011 CINCO DIAS (Page 18) LEGAL
ANNOUNCEMENTS
El accionista único de CRYSTAL PHARMA SA (Sdad. Absorbente) acordó el
03/10/11 la fusión por absorción de RAGACTIVES SL (Sdad. Absorbida).
15/04/2008 EL MUNDO DE CASTILLA Y LEÓN - GENERAL
INFORMATION
GADEA PHARMACEUTICAL GROUP ES UNA CIA. HOLDING UBICADA EN EL PARQUE
TECNOLOGICO DE BOECILLO (VALLADOLID) COMPUESTA POR 3 EMPRESAS QUIMICAS:
REGACTIVES, CRYSTAL PHARMA Y BLASCHEM (EN MALTA), MAS UNA CUARTA EMPRESA EN
CREACION Y CUYA UBICACION SERA EN SORIA. SERA UNA EMPRESA 100% FARMACEUTICA,
DEDICADA A LA PRODUCCION DE MEDICAMENTOS Y ESTARA PARTICIPADA EN UN 50% POR EL
GRUPO GADEA Y EL RESTO POR UN SOCIAL INDUSTRIAL. ASIMISMO, CRYSTAL PHARMA
CUENTA CON 98 EMPLEADOS EN SU FABRICA DE BOECILLO Y FACTURA EL 82% DE LOS 37,5
MM. DE DOLARES DEL GRUPO. EL 90% DE SUS VENTAS PROCEDE DE LA EXPORTACION Y SU
CARTERA DE CLIENTES LA FORMAN GRANDES CIAS. EN EUROPA, EEUU, JAPON Y
CANADA.
18/11/2006 EL MUNDO DE CASTILLA Y
LEÓN - FINANCIAL DATA
EN 1998 CRYSTAL PHARMA Y RAGACTIVES FACTURARON CONJUNTAMENTE 2,1 MM. DE
EUROS, Y ESTE AŃO, YA BAJO LA DENOMINACION DE GADEA PHARMACEUTICAL GROUP,
ESPERAN SUPERAR LOS 26 MM. LA ESTIMACION DE VENTAS PARA 2008 ES DE ALREDEDOR DE
40 MM. DE EUROS. LA ULTIMA INVERSION REALIZADA POR LA CIA. DURANTE ESTE AŃO HA
ALCANZADO LOS 6,2 MM. DE EUROS, CON LA CONSTRUCCION DE UNA NUEVA PLANTA DE
ELABORACION DE PRINCIPIOS ACTIVOS QUE PERMITIRA TRIPLICAR LA ACTUAL
PRODUCCION.
05/11/2006 EL MUNDO DE CASTILLA Y LEÓN - GENERAL
INFORMATION
DOS EMPRESAS DEL SECTOR QUIMICO Y FARMACEUTICO, CRYSTAL PHARMA Y
RAGACTIVES, SE HAN FUSIONADO Y HAN CREADO GADEA PHARMACEUTICAL GROUP, DE CUYA
INTEGRACION EMERGE UN HOLDING CON UNOS ACTIVOS VALORADOS EN 23 MM. DE EUROS Y
UNAS PREVISIONES DE VENTAS SUPERIORES A 40 MM. DE EUROS EN 2008, LO QUE
REPRESENTA UN RITMO DE CRECIMIENTO DE SU NEGOCIO DEL 30% ANUAL. LA CIA.
FUSIONADA ESTA CONTROLADA EN UN 33% POR LA CATALANA GENTEC Y EXPORTA EL 90% DE
SU PRODUCCION A EE.UU., JAPON Y LA UNION EUROPEA.
There are 17 press articles registered for this company
FINANCIAL INFORMATION
The information on the last Individual Filed Accounts contained in this report is extracted from the Mercantile Register file of the legal address of the Company and dated 06/09/2012.
SITUATION
BALANCE-SHEET
Assets
Figures given in thousands €
|
|
31/12/2011 (12) |
% ASSETS |
31/12/2010 (12) |
% ASSETS |
31/12/2009 (12) |
% ASSETS |
|
A) NON CURRENT ASSETS |
13.323,00 |
29,79 |
9.265,48 |
28,72 |
11.008,84 |
40,44 |
|
I. Intangible assets |
3.150,00 |
7,04 |
987,26 |
3,06 |
1.537,34 |
5,65 |
|
1. Development |
630,00 |
1,41 |
987,26 |
3,06 |
1.536,83 |
5,65 |
|
3. Patents, licences , trademarks and similars |
1.820,00 |
4,07 |
|
|
|
|
|
4. Goodwill |
699,00 |
1,56 |
|
|
|
|
|
5. Software |
1,00 |
0,00 |
|
|
0,52 |
0,00 |
|
II. Tangible fixed assets |
9.983,00 |
22,32 |
8.098,78 |
25,10 |
8.268,99 |
30,37 |
|
1. Property, plant and equipment |
3.986,00 |
8,91 |
3.072,61 |
9,52 |
2.805,35 |
10,30 |
|
2. Technical fittings and other tangible assets |
5.872,00 |
13,13 |
4.746,87 |
14,71 |
5.243,28 |
19,26 |
|
3. Fixed assets in progress and advances |
125,00 |
0,28 |
279,30 |
0,87 |
220,36 |
0,81 |
|
III. Real-estate investments |
|
|
|
|
|
|
|
IV. Long term investments in associated and affiliated companies |
|
|
|
|
777,54 |
2,86 |
|
2. Credits to companies |
|
|
|
|
777,54 |
2,86 |
|
V. Long Term Financial Investments |
19,00 |
0,04 |
11,36 |
0,04 |
10,11 |
0,04 |
|
1. Net worth instruments |
10,00 |
0,02 |
5,73 |
0,02 |
5,73 |
0,02 |
|
5. Other financial assets |
9,00 |
0,02 |
5,63 |
0,02 |
4,38 |
0,02 |
|
VI. Assets by deferred taxes |
171,00 |
0,38 |
168,08 |
0,52 |
414,86 |
1,52 |
|
VII. Non current commercial debts |
|
|
|
|
|
|
|
B) CURRENT ASSETS |
31.405,00 |
70,21 |
22.997,08 |
71,28 |
16.215,07 |
59,56 |
|
I. Non-current assets maintained for sale |
|
|
|
|
|
|
|
II. Stocks |
15.559,00 |
34,79 |
10.350,52 |
32,08 |
8.261,68 |
30,35 |
|
2. Raw material inventory |
3.968,00 |
8,87 |
2.972,69 |
9,21 |
1.972,89 |
7,25 |
|
3. Work in Progress |
3.480,00 |
7,78 |
2.183,87 |
6,77 |
2.859,09 |
10,50 |
|
b) Short production cycle |
3.480,00 |
7,78 |
2.183,87 |
6,77 |
2.859,09 |
10,50 |
|
4. Finished goods |
8.110,00 |
18,13 |
5.186,50 |
16,08 |
3.429,70 |
12,60 |
|
b) Short production cycle |
8.110,00 |
18,13 |
5.186,50 |
16,08 |
3.429,70 |
12,60 |
|
6. Pre-payments to suppliers |
1,00 |
0,00 |
7,46 |
0,02 |
|
|
|
III. Trade Debtors and other receivable accounts |
13.402,00 |
29,96 |
10.136,24 |
31,42 |
6.627,83 |
24,35 |
|
1. Clients |
10.598,00 |
23,69 |
9.212,91 |
28,56 |
4.504,21 |
16,55 |
|
b) Clients for sales and short term services
rendering |
10.598,00 |
23,69 |
9.212,91 |
28,56 |
4.504,21 |
16,55 |
|
2. Clients group and associated companies |
1.516,00 |
3,39 |
411,57 |
1,28 |
976,19 |
3,59 |
|
4. Staff |
|
|
|
|
37,65 |
0,14 |
|
6. Other credits with the Public Administrations |
1.288,00 |
2,88 |
511,76 |
1,59 |
1.109,78 |
4,08 |
|
IV. Short term investments in associated and affiliated companies |
|
|
|
|
|
|
|
V. Short term financial investments |
|
|
|
|
|
|
|
VI. Short term periodifications |
|
|
|
|
|
|
|
VII. Cash and equivalents |
2.444,00 |
5,46 |
2.510,32 |
7,78 |
1.325,55 |
4,87 |
|
1. Treasury |
2.444,00 |
5,46 |
2.500,32 |
7,75 |
1.325,55 |
4,87 |
|
2. Other cash equivalents |
|
|
10,00 |
0,03 |
|
|
|
TOTAL ASSETS (A + B) |
44.728,00 |
100,00 |
32.262,56 |
100,00 |
27.223,91 |
100,00 |
Net Worth and
Liabilities
Figures given in thousands €
|
|
31/12/2011 (12) |
% ASSETS |
31/12/2010 (12) |
% ASSETS |
31/12/2009 (12) |
% ASSETS |
|
A) NET WORTH |
26.180,00 |
58,53 |
13.160,44 |
40,79 |
13.195,16 |
48,47 |
|
A-1) Equity |
25.394,00 |
56,77 |
12.247,32 |
37,96 |
12.099,39 |
44,44 |
|
I. Capital |
2.000,00 |
4,47 |
2.000,00 |
6,20 |
2.000,00 |
7,35 |
|
1. Authorized capital |
2.000,00 |
4,47 |
2.000,00 |
6,20 |
2.000,00 |
7,35 |
|
II. Issue premium |
|
|
|
|
|
|
|
III. Reserves |
16.266,00 |
36,37 |
7.349,39 |
22,78 |
7.934,84 |
29,15 |
|
1. Legal and statutory |
400,00 |
0,89 |
400,00 |
1,24 |
400,00 |
1,47 |
|
2. Other funds |
15.866,00 |
35,47 |
6.949,39 |
21,54 |
7.534,84 |
27,68 |
|
IV. (Net worth own shares and participations) |
|
|
|
|
|
|
|
V. Results from previous years |
|
|
|
|
|
|
|
VI. Other loans from partners |
|
|
|
|
|
|
|
VII. Exercise Result |
7.128,00 |
15,94 |
2.897,93 |
8,98 |
2.164,55 |
7,95 |
|
VIII. (Interim dividend) |
|
|
|
|
|
|
|
IX. Other net worth instruments |
|
|
|
|
|
|
|
A-2) Value changes adjustments |
-50,00 |
-0,11 |
-42,20 |
-0,13 |
-35,07 |
-0,13 |
|
I. Financial assets available for sale |
-50,00 |
-0,11 |
|
|
|
|
|
II. Coverage operations |
|
|
-42,20 |
-0,13 |
-35,07 |
-0,13 |
|
III. Non-current assets and related liabilities, maintained for sale |
|
|
|
|
|
|
|
IV. Conversion differences |
|
|
|
|
|
|
|
V. Other |
|
|
|
|
|
|
|
A-3) Received legacies, grants and subventions |
836,00 |
1,87 |
955,32 |
2,96 |
1.130,85 |
4,15 |
|
B) NON CURRENT LIABILITIES |
3.331,00 |
7,45 |
9.105,59 |
28,22 |
1.455,95 |
5,35 |
|
I. Long term provisions |
|
|
|
|
|
|
|
II. Long term debts |
1.968,00 |
4,40 |
3.062,27 |
9,49 |
892,02 |
3,28 |
|
2. Debts with bank entities |
1.324,00 |
2,96 |
2.110,43 |
6,54 |
769,15 |
2,83 |
|
5. Other financial liabilities |
644,00 |
1,44 |
951,84 |
2,95 |
122,86 |
0,45 |
|
III. Long term debts with associated and affiliated companies |
242,00 |
0,54 |
5.574,43 |
17,28 |
|
|
|
IV. Liabilities by deferred taxes |
1.121,00 |
2,51 |
468,88 |
1,45 |
563,93 |
2,07 |
|
V. Long term periodifications |
|
|
|
|
|
|
|
VI. Non current trade creditors |
|
|
|
|
|
|
|
VII. Long term debts with special characteristics |
|
|
|
|
|
|
|
C) CURRENT LIABILITIES |
15.217,00 |
34,02 |
9.996,52 |
30,98 |
12.572,79 |
46,18 |
|
I. Liabilities related with non-current assets maintained for sale |
|
|
|
|
|
|
|
II. Short term provisions |
|
|
|
|
|
|
|
III. Short term debts |
3.586,00 |
8,02 |
1.968,36 |
6,10 |
2.997,84 |
11,01 |
|
2. Debts with bank entities |
3.191,00 |
7,13 |
1.584,03 |
4,91 |
2.908,53 |
10,68 |
|
4. By-products |
71,00 |
0,16 |
60,28 |
0,19 |
50,10 |
0,18 |
|
5. Other financial liabilities |
324,00 |
0,72 |
324,05 |
1,00 |
39,21 |
0,14 |
|
IV. Short term debts with associated and affiliated companies |
2.517,00 |
5,63 |
819,19 |
2,54 |
4.575,44 |
16,81 |
|
V. Trade creditors and other payable accounts |
9.114,00 |
20,38 |
7.208,98 |
22,34 |
4.999,52 |
18,36 |
|
1. Suppliers |
6.592,00 |
14,74 |
4.448,59 |
13,79 |
1.875,32 |
6,89 |
|
b) Short term suppliers |
6.592,00 |
14,74 |
4.448,59 |
13,79 |
1.875,32 |
6,89 |
|
2. Suppliers group and associated companies |
517,00 |
1,16 |
739,44 |
2,29 |
1.933,17 |
7,10 |
|
3. Different creditors |
1.307,00 |
2,92 |
1.406,84 |
4,36 |
697,97 |
2,56 |
|
4. Staff (pending remunerations) |
436,00 |
0,97 |
310,35 |
0,96 |
276,10 |
1,01 |
|
6. Other debts with Public Administrations |
262,00 |
0,59 |
204,63 |
0,63 |
166,43 |
0,61 |
|
7. Clients pre-payments |
|
|
99,12 |
0,31 |
50,52 |
0,19 |
|
VI. Short term periodifications |
|
|
|
|
|
|
|
VII. Short term debts with special characteristics |
|
|
|
|
|
|
|
TOTAL NET WORTH AND LIABILITIES (A + B + C) |
44.728,00 |
100,00 |
32.262,56 |
100,00 |
27.223,91 |
100,00 |
PROFIT AND LOSS ACCOUNT
Figures given in
thousands €
|
|
31/12/2011 (12) |
%OPERATING INCOME |
31/12/2010 (12) |
%OPERATING INCOME |
31/12/2009 (12) |
%OPERATING INCOME |
|
A) CONTINUED OPERATIONS |
|
|
|
|
|
|
|
1. Net Turnover |
49.097,00 |
98,49 |
33.367,84 |
98,94 |
22.716,87 |
94,80 |
|
A) Sales |
49.029,00 |
98,35 |
32.900,59 |
97,55 |
22.492,86 |
93,86 |
|
b) Services provided |
68,00 |
0,14 |
467,25 |
1,39 |
224,01 |
0,93 |
|
2. Variation in stocks of finished goods and work in progress |
2.872,00 |
5,76 |
1.081,58 |
3,21 |
1.284,55 |
5,36 |
|
3. Works for its own assets |
|
|
|
|
573,49 |
2,39 |
|
4. Supplies |
-26.847,00 |
-53,85 |
-20.842,43 |
-61,80 |
-14.029,25 |
-58,54 |
|
a) Material consumed |
-2.757,00 |
-5,53 |
-2.221,39 |
-6,59 |
-1.494,50 |
-6,24 |
|
b) Raw materials consumed |
-20.251,00 |
-40,62 |
-17.193,46 |
-50,98 |
-11.635,88 |
-48,56 |
|
c) Works carried out for other companies |
-3.839,00 |
-7,70 |
-1.427,59 |
-4,23 |
-898,86 |
-3,75 |
|
5. Other operating income |
754,00 |
1,51 |
357,95 |
1,06 |
673,46 |
2,81 |
|
a) Other incomes |
152,00 |
0,30 |
146,28 |
0,43 |
468,40 |
1,95 |
|
b) Operating grants included in the exercise result |
602,00 |
1,21 |
211,67 |
0,63 |
205,06 |
0,86 |
|
6. Labour cost |
-4.918,00 |
-9,87 |
-3.509,81 |
-10,41 |
-3.427,41 |
-14,30 |
|
a) Wages and similar expenses |
-3.691,00 |
-7,40 |
-2.634,58 |
-7,81 |
-2.531,00 |
-10,56 |
|
b) Social costs |
-1.227,00 |
-2,46 |
-875,23 |
-2,60 |
-896,41 |
-3,74 |
|
7. Other operating costs |
-7.080,00 |
-14,20 |
-4.452,48 |
-13,20 |
-3.047,45 |
-12,72 |
|
a) External services |
-7.028,00 |
-14,10 |
-4.176,19 |
-12,38 |
-3.025,55 |
-12,63 |
|
b) Taxes |
-32,00 |
-0,06 |
-16,20 |
-0,05 |
-17,27 |
-0,07 |
|
c) Losses, deterioration and variation on business operations
provisions |
-20,00 |
-0,04 |
-3,59 |
-0,01 |
-1,11 |
0,00 |
|
d) Other day to day expenses |
|
|
-256,49 |
-0,76 |
-3,52 |
-0,01 |
|
8. Amortization of fixed assets |
-4.455,00 |
-8,94 |
-2.112,27 |
-6,26 |
-1.929,22 |
-8,05 |
|
9. Allocation of subventions on non financial investments and other |
353,00 |
0,71 |
403,15 |
1,20 |
344,59 |
1,44 |
|
10. Provisions excess |
|
|
|
|
|
|
|
11. Deterioration and result for fixed assets disposal |
-4,00 |
-0,01 |
-0,90 |
0,00 |
-25,69 |
-0,11 |
|
b) Results for disposals and others |
-4,00 |
-0,01 |
-0,90 |
0,00 |
-25,69 |
-0,11 |
|
12. Negative difference of business combinations |
|
|
|
|
|
|
|
13. Other results |
|
|
|
|
|
|
|
A.1) OPERATING RESULT (1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9 + 10 + 11 +
12 + 13) |
9.772,00 |
19,60 |
4.292,62 |
12,73 |
3.133,94 |
13,08 |
|
14. Financial income |
47,00 |
0,09 |
60,60 |
0,18 |
3,14 |
0,01 |
|
b) From negotiable values and other financial instruments |
47,00 |
0,09 |
60,60 |
0,18 |
3,14 |
0,01 |
|
b 1) From group and associated companies |
42,00 |
0,08 |
15,55 |
0,05 |
|
|
|
b 2) From third parties |
5,00 |
0,01 |
45,05 |
0,13 |
3,14 |
0,01 |
|
15. Financial expenses |
-343,00 |
-0,69 |
-372,29 |
-1,10 |
-254,50 |
-1,06 |
|
a) For debts with associated and affiliated companies |
-148,00 |
-0,30 |
-102,26 |
-0,30 |
|
|
|
b) For debts with third parties |
-195,00 |
-0,39 |
-270,03 |
-0,80 |
-254,50 |
-1,06 |
|
16. Reasonable value variation on financial instruments |
|
|
|
|
|
|
|
17. Exchange differences |
-7,00 |
-0,01 |
96,66 |
0,29 |
-42,15 |
-0,18 |
|
18. Deterioration and result for disposal of financial instruments |
|
|
|
|
|
|
|
19. Other financial income and expenses |
|
|
|
|
|
|
|
A.2) FINANCIAL RESULT (14 + 15 + 16 + 17 + 18 + 19) |
-303,00 |
-0,61 |
-215,03 |
-0,64 |
-293,51 |
-1,22 |
|
A.3) RESULT BEFORE TAXES (A.1 + A.2) |
9.469,00 |
18,99 |
4.077,59 |
12,09 |
2.840,43 |
11,85 |
|
20. Taxes on profits |
-2.341,00 |
-4,70 |
-1.179,66 |
-3,50 |
-675,88 |
-2,82 |
|
A.4) EXERCISE RESULT COMING FROM CONTINUED OPERATIONS (A.3 + 20) |
7.128,00 |
14,30 |
2.897,93 |
8,59 |
2.164,55 |
9,03 |
|
B) DISCONTINUED OPERATIONS |
|
|
|
|
|
|
|
21. Net of taxes exercise result coming from discontinued operations |
|
|
|
|
|
|
|
A.5) EXERCISE RESULT (A.4 + 21) |
7.128,00 |
14,30 |
2.897,93 |
8,59 |
2.164,55 |
9,03 |
NET WORTH CHANGES STATUS
Status of recognized income and expenses
Figures given in thousands €
|
NET WORTH CHANGES (1/3) |
31/12/2011 (12) |
31/12/2010 (12) |
31/12/2009 (12) |
|
A) PROFIT AND LOSS ACCOUNT RESULT |
7.128,00 |
2.897,93 |
2.164,55 |
|
INCOME AND EXPENSES ALLOCATED DIRECTLY TO NET WORTH |
|
|
|
|
I. For valuation of financial instruments |
|
|
|
|
II. Cash flow coverage |
-11,00 |
-10,18 |
-18,39 |
|
III. Received legacies, grants and subventions |
|
152,40 |
1.736,33 |
|
IV. For actuarial profits and losses and other adjustments |
|
|
|
|
V. Non-current assets and related liabilities, maintained for sale |
|
|
|
|
VI. Conversion differences |
|
|
|
|
VII. Tax effect |
3,00 |
-42,67 |
-515,38 |
|
B) TOTAL INCOME AND EXPENSES ALLOCATED DIRECTLY TO NET WORTH (I + II +
III + IV +V+VI+VII) |
-8,00 |
99,55 |
1.202,55 |
|
PROFIT AND LOSS ACCOUNT TRANSFERS |
|
|
|
|
VIII. For valuation of financial instruments |
|
|
|
|
IX. Cash flow coverage |
|
|
|
|
X. Received legacies, grants and subventions |
-353,00 |
-403,15 |
-344,59 |
|
XI. Non-current assets and related liabilities, maintained for sale |
|
|
|
|
XII. Conversion differences |
|
|
|
|
XIII. Tax effect |
107,00 |
120,94 |
103,38 |
|
C) TOTAL TRANSFERS TO THE PROFIT AND LOSS ACCOUNT (VIII + IX + X + XI+
XII+ XIII) |
-246,00 |
-282,20 |
-241,21 |
|
TOTAL INCOME AND EXPENSES RECOGNIZED (A + B + C) |
6.874,00 |
2.715,28 |
3.125,89 |
Total net worth
changes status
Figures given in thousands €
|
NET WORTH CHANGES ( 2 /3) |
AUTHORIZED CAPITAL |
RESERVES |
EXERCISE RESULT |
VALUE CHANGES ADJUSTMENTS |
|
FINAL ACCOUNT BALANCE OF EXERCISE (2008) |
2.000,00 |
7.199,43 |
1.015,41 |
-22,20 |
|
I. Adjustments by change of criteria in the exercise (2008) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2008) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2009) |
2.000,00 |
7.199,43 |
1.015,41 |
-22,20 |
|
I. Total recognized income and expenses |
|
|
2.164,55 |
-12,88 |
|
II. Operations with partners or owners |
|
|
-1.015,41 |
|
|
4. (-) Dividends distribution |
|
|
-280,00 |
|
|
7. Other operations with partners or owners |
|
|
-735,41 |
|
|
III. Other net worth variations |
|
735,41 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2009) |
2.000,00 |
7.934,84 |
2.164,55 |
-35,07 |
|
I. Adjustments by change of criteria in the exercise (2009) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2009) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2010) |
2.000,00 |
7.934,84 |
2.164,55 |
-35,07 |
|
I. Total recognized income and expenses |
|
|
2.897,93 |
-7,12 |
|
II. Operations with partners or owners |
|
1.664,55 |
-2.164,55 |
|
|
4. (-) Dividends distribution |
|
|
-500,00 |
|
|
7. Other operations with partners or owners |
|
1.664,55 |
-1.664,55 |
|
|
III. Other net worth variations |
|
-2.250,00 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2010) |
2.000,00 |
7.349,00 |
2.898,00 |
-42,00 |
|
I. Adjustments by change of criteria in the exercise (2010) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2010) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2011) |
2.000,00 |
7.349,00 |
2.898,00 |
-42,00 |
|
I. Total recognized income and expenses |
|
|
7.128,00 |
-8,00 |
|
II. Operations with partners or owners |
|
9.217,00 |
-2.898,00 |
|
|
4. (-) Dividends distribution |
|
|
-1.200,00 |
|
|
7. Other operations with partners or owners |
|
9.217,00 |
-1.698,00 |
|
|
III. Other net worth variations |
|
-300,00 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2011) |
2.000,00 |
16.266,00 |
7.128,00 |
-50,00 |
|
NET WORTH CHANGES ( 3 /3) |
RECEIVED LEGACIES, GRANTS AND SUBVENTIONS |
TOTAL |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2008) |
156,63 |
10.349,27 |
|
|
|
I. Adjustments by change of criteria in the exercise (2008) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2008) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2009) |
156,63 |
10.349,27 |
|
|
|
I. Total recognized income and expenses |
974,22 |
3.125,89 |
|
|
|
II. Operations with partners or owners |
|
-1.015,41 |
|
|
|
4. (-) Dividends distribution |
|
-280,00 |
|
|
|
7. Other operations with partners or owners |
|
-735,41 |
|
|
|
III. Other net worth variations |
|
735,41 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2009) |
1.130,85 |
13.195,16 |
|
|
|
I. Adjustments by change of criteria in the exercise (2009) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2009) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2010) |
1.130,85 |
13.195,16 |
|
|
|
I. Total recognized income and expenses |
-175,52 |
2.715,28 |
|
|
|
II. Operations with partners or owners |
|
-500,00 |
|
|
|
4. (-) Dividends distribution |
|
-500,00 |
|
|
|
7. Other operations with partners or owners |
|
|
|
|
|
III. Other net worth variations |
0,00 |
-2.250,00 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2010) |
955,00 |
13.160,00 |
|
|
|
I. Adjustments by change of criteria in the exercise (2010) |
|
|
|
|
|
II. Adjustments by errors in the exercise (2010) |
|
|
|
|
|
ADJUSTED ACCOUNT BALANCE, BEGINNING OF EXERCISE (2011) |
955,00 |
13.160,00 |
|
|
|
I. Total recognized income and expenses |
-246,00 |
6.874,00 |
|
|
|
II. Operations with partners or owners |
127,00 |
6.446,00 |
|
|
|
4. (-) Dividends distribution |
|
-1.200,00 |
|
|
|
7. Other operations with partners or owners |
127,00 |
7.646,00 |
|
|
|
III. Other net worth variations |
|
-300,00 |
|
|
|
FINAL ACCOUNT BALANCE OF EXERCISE (2011) |
836,00 |
26.180,00 |
|
|
CASH FLOW STATUS
Figures given in thousands €
|
|
31/12/2011 (12) |
31/12/2010 (12) |
31/12/2009 (12) |
|
A) CASH FLOW COMING FROM OPERATING ACTIVITIES |
|
|
|
|
1. exercise result before taxes |
9.469,00 |
4.077,59 |
2.840,43 |
|
2. Results adjustments |
4.405,00 |
1.925,05 |
1.899,83 |
|
a) Amortization of fixed assets (+) |
4.455,00 |
2.112,27 |
1.929,22 |
|
d) Grants allocation (-) |
-353,00 |
-403,15 |
-344,59 |
|
e) Results for decline and disposal of fixed assets (+/-) |
|
0,90 |
25,69 |
|
g) Financial income (-) |
-47,00 |
-60,60 |
-3,14 |
|
f) Financial expenses (+) |
343,00 |
372,29 |
254,50 |
|
i) Change difference (+/-) |
7,00 |
-96,66 |
42,15 |
|
k) Other income and expenses (-/+) |
|
|
-4,00 |
|
3. Changes in current capital |
-2.454,00 |
-3.744,67 |
-75,00 |
|
a) Stocks (+/-) |
-3.084,00 |
-2.088,84 |
-408,51 |
|
b) Debtors and other receivable accounts (+/-) |
287,00 |
-3.508,40 |
-1.142,00 |
|
d) Creditors and other payable accounts (+/-) |
343,00 |
1.852,57 |
1.475,51 |
|
4. Other cash flow coming from operating activities |
-2.980,00 |
-829,13 |
-294,36 |
|
a) Interests payments (-) |
-343,00 |
-372,29 |
-254,50 |
|
b) Dividends collections (+) |
|
|
3,14 |
|
c) Interests collections (+) |
47,00 |
60,60 |
|
|
d) Collections (payments) for profit tax (+/-) |
-2.684,00 |
-517,44 |
-43,00 |
|
5. Cash flow coming from operating activities (1 + 2 + 3 + 4) |
8.440,00 |
1.428,84 |
4.370,90 |
|
B) CASH FLOW COMING FROM INVESTING ACTIVITIES |
|
|
|
|
6. Investment payments (-) |
-776,00 |
-1.394,12 |
-890,00 |
|
b) Intangible assets |
-1,00 |
|
-573,00 |
|
c) Tangible assets |
-775,00 |
-1.392,87 |
-316,00 |
|
e) Other financial assets |
|
-1,25 |
|
|
h) Other assets |
|
|
-1,00 |
|
7. Disinvestment collections (+) |
|
777,54 |
33,00 |
|
a) Group and associated companies |
|
777,54 |
|
|
c) Tangible assets |
|
|
9,00 |
|
e) Other financial assets |
|
|
24,00 |
|
8. Cash Flow in investment activities (6 + 7) |
-776,00 |
-616,58 |
-857,00 |
|
C) CASH FLOW COMING FROM FINANCING ACTIVITIES |
|
|
|
|
9. Net worth instruments collections and payments |
|
152,40 |
1.055,00 |
|
e) Received legacies, grants and subventions (+) |
|
152,40 |
1.055,00 |
|
10. Financial liabilities instruments collections and payments |
-6.695,00 |
2.894,29 |
-3.770,00 |
|
a) Issue |
2.403,00 |
5.996,58 |
1.905,00 |
|
2. Debts with bank entities (+) |
|
2.500,00 |
|
|
3. Debts with group and associated companies (+) |
|
1.818,18 |
1.905,00 |
|
5. Other debts (+) |
2.403,00 |
1.678,40 |
|
|
b) Return and amortization of |
-9.098,00 |
-3.102,29 |
-5.675,00 |
|
2. Debts with bank entities (-) |
-1.763,00 |
-2.493,40 |
-5.636,00 |
|
3. Debts with group and associated companies (-) |
-6.078,00 |
|
|
|
5. Other debts (-) |
-1.257,00 |
-608,89 |
-39,00 |
|
11. Payments for dividends and remunerations of other net worth
instruments |
-1.500,00 |
-2.750,00 |
-280,00 |
|
a) Dividends (-) |
-1.500,00 |
-2.750,00 |
-280,00 |
|
12. Cash Flow in financing activities (9 + 10 + 11) |
-8.195,00 |
296,69 |
-2.995,00 |
|
D) Exchange rate variations effect |
-42,00 |
75,82 |
-94,08 |
|
E) NET CASH OR EQUIVALENTS INCREASE / REDUCTION (5 + 8 + 12 + D) |
-573,00 |
1.184,77 |
424,82 |
|
Cash or equivalents at the beginning of the exercise |
3.017,00 |
1.325,55 |
900,73 |
|
Cash or equivalents at the end of the exercise |
2.444,00 |
2.510,32 |
1.325,55 |
RATIOS
|
|
31/12/2011 (12) |
CHANGE % |
31/12/2010 (12) |
CHANGE % |
31/12/2009 (12) |
|
BALANCE RATIOS |
|||||
|
Working Capital (€) |
16.188,00 |
24,52 |
13.000,55 |
256,93 |
3.642,28 |
|
Working capital ratio |
0,36 |
-10,00 |
0,40 |
207,69 |
0,13 |
|
Soundness Ratio |
1,91 |
44,70 |
1,32 |
20,00 |
1,10 |
|
Average Collection Period (days) |
98 |
-10,20 |
109 |
4,11 |
105 |
|
Average Payment Period (days) |
123 |
8,20 |
114 |
-43,49 |
202 |
|
LIQUIDITY RATIOS |
|||||
|
Current Ratio (%) |
206,38 |
-10,29 |
230,05 |
78,37 |
128,97 |
|
Quick Ratio (%) |
16,06 |
-36,04 |
25,11 |
138,24 |
10,54 |
|
DEBT RATIOS |
|||||
|
Borrowing percentage (%) |
18,59 |
-47,50 |
35,41 |
13,86 |
31,10 |
|
External Financing Average Cost |
0,04 |
33,33 |
0,03 |
0,00 |
0,03 |
|
Debt Service Coverage |
0,98 |
-87,62 |
8,00 |
312,37 |
1,94 |
|
Interest Coverage |
28,49 |
147,09 |
11,53 |
-6,34 |
12,31 |
|
GENERAL AND ACTIVITIES RATIOS |
|||||
|
Auto financing generated by sales (%) |
17,19 |
301,64 |
4,28 |
-77,75 |
19,24 |
|
Auto financing generated by Assets (%) |
18,87 |
325,96 |
4,43 |
-72,42 |
16,06 |
|
Breakdown Point |
1,25 |
8,70 |
1,15 |
-0,86 |
1,16 |
|
Average Sales Volume per Employee |
353,85 |
4,37 |
339,04 |
49,50 |
226,78 |
|
Average Cost per Employee |
35,44 |
-0,59 |
35,66 |
4,21 |
34,22 |
|
Assets Turnover |
1,10 |
6,80 |
1,03 |
24,10 |
0,83 |
|
Inventory Turnover (days) |
209 |
16,70 |
179 |
-15,62 |
212 |
|
RESULTS RATIOS |
|||||
|
Return on Assets (ROA) (%) |
21,85 |
64,16 |
13,30 |
15,64 |
11,51 |
|
Operating Profitability (%) |
31,80 |
60,20 |
19,85 |
7,30 |
18,50 |
|
Return on Equity (ROE) (%) |
37,29 |
12,02 |
33,29 |
41,78 |
23,48 |
SECTORIAL ANALYSIS
Balance Sheet and
Financial Balance
Figures expressed in %
|
|
COMPANY (2011) |
SECTOR |
DIFFERENCE |
|
BALANCE SHEET ANALYSIS: % on the total
assets |
|
|
|
|
ASSETS |
|||
|
A) NON CURRENT ASSETS |
29,79 |
29,69 |
0,09 |
|
A) CURRENT ASSETS |
70,21 |
70,31 |
-0,09 |
|
LIABILITIES |
|||
|
A) NET WORTH |
58,53 |
49,70 |
8,83 |
|
B) NON CURRENT LIABILITIES |
7,45 |
6,41 |
1,03 |
|
C) CURRENT LIABILITIES |
34,02 |
43,88 |
-9,86 |
Results Analytical
Account
Figures given in %
|
|
COMPANY (2011) |
SECTOR |
DIFFERENCE |
|
Net Turnover |
98,49 |
95,69 |
2,80 |
|
Other operating income |
1,51 |
4,31 |
-2,80 |
|
OPERATING INCOME |
100,00 |
100,00 |
0,00 |
|
Supplies |
-53,85 |
-57,83 |
3,98 |
|
Variation in stocks of finished goods and work in progress |
5,76 |
0,18 |
5,58 |
|
GROSS MARGIN |
51,91 |
42,34 |
9,56 |
|
Other operating costs |
-14,20 |
-19,23 |
5,03 |
|
Labour cost |
-9,87 |
-14,60 |
4,73 |
|
GROSS OPERATING RESULT |
27,84 |
8,51 |
19,33 |
|
Amortization of fixed assets |
-8,94 |
-2,22 |
-6,72 |
|
Deterioration and result for fixed assets disposal |
-0,01 |
-0,06 |
0,05 |
|
Other expenses / income |
|
0,13 |
|
|
NET OPERATING RESULT |
19,60 |
6,37 |
13,23 |
|
Financial result |
-0,61 |
0,19 |
-0,80 |
|
RESULT BEFORE TAX |
18,99 |
6,56 |
12,43 |
|
Taxes on profits |
-4,70 |
-1,67 |
-3,03 |
|
RESULT COMING FROM CONTINUED OPERATIONS |
14,30 |
4,89 |
9,41 |
|
Exercise result coming from discontinued operations net of taxes |
|
0,00 |
|
|
NET RESULT |
14,30 |
4,89 |
9,41 |
|
Amortization of fixed assets |
-8,94 |
-2,22 |
-6,72 |
|
Deterioration and provisions variation |
-8,98 |
-0,15 |
-8,83 |
|
|
32,21 |
7,26 |
24,95 |
Main Ratios
Figures given in thousands €
|
|
COMPANY (2011) |
PTILE25 |
PTILE50 |
PTILE75 |
|
BALANCE RATIOS |
|
|
|
|
|
Working Capital (€) |
16.188,00 |
14.503.272,00 |
23.025.541,50 |
62.153.000,00 |
|
Working capital ratio |
0,36 |
0,18 |
0,30 |
0,35 |
|
Soundness Ratio |
1,91 |
1,12 |
1,56 |
1,86 |
|
Average Collection Period (days) |
98 |
61 |
101 |
114 |
|
Average Payment Period (days) |
123 |
78 |
120 |
196 |
|
LIQUIDITY RATIOS |
|
|
|
|
|
Current Ratio (%) |
206,38 |
151,29 |
207,99 |
227,36 |
|
Quick Ratio (%) |
16,06 |
3,60 |
8,07 |
12,31 |
|
DEBT RATIOS |
|
|
|
|
|
Borrowing percentage (%) |
18,59 |
12,05 |
14,88 |
27,03 |
|
External Financing Average Cost |
0,04 |
0,02 |
0,03 |
0,08 |
|
Debt Service Coverage |
0,98 |
0,89 |
1,26 |
2,75 |
|
Interest Coverage |
28,49 |
4,33 |
17,70 |
41,78 |
|
GENERAL AND ACTIVITIES RATIOS |
|
|
|
|
|
Auto financing generated by sales (%) |
17,19 |
6,82 |
10,62 |
12,78 |
|
Auto financing generated by Assets (%) |
18,87 |
7,49 |
11,51 |
13,64 |
|
Breakdown Point |
1,25 |
1,05 |
1,07 |
1,10 |
|
Average Sales Volume per Employee |
353,85 |
161.483,68 |
315.043,94 |
481.127,76 |
|
Average Cost per Employee |
35,44 |
42.057,31 |
52.878,71 |
65.670,55 |
|
Assets Turnover |
1,10 |
0,78 |
1,11 |
1,41 |
|
Inventory Turnover (days) |
209 |
70 |
125 |
161 |
|
RESULTS RATIOS |
|
|
|
|
|
Return on Assets (ROA) (%) |
21,85 |
3,86 |
7,40 |
10,92 |
|
Operating Profitability (%) |
31,80 |
8,18 |
13,11 |
15,58 |
|
Return on Equity (ROE) (%) |
37,29 |
8,57 |
13,23 |
30,68 |
ADDITIONAL INFORMATION
Consulted Sources
Tax Administration / VIES Consultation
Tax Administration / Consultation by NIF
INTERNET
Telephone directory: PÁGINAS AMARILLAS
Telephone directory: PÁGINAS BLANCAS
This company has been consulted was last displayed on 14/12/2012,
28 times in the last quarter and 1.357 total times.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.63 |
|
UK Pound |
1 |
Rs.88.40 |
|
Euro |
1 |
Rs.71.86 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.